This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Audrey Graham Ross: Innovator in Pharmaceutical Chemistry
Introduction
Audrey Graham Ross is a distinguished inventor based in Cambridge, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzyme activities.
Latest Patents
Audrey holds a patent for "Heterocyclic PAD4 inhibitors," which relates to substituted heterocyclic compounds of Formula (Ia). These compounds are designed to inhibit the PAD4 enzyme, and the patent outlines methods for preparing these compounds, as well as pharmaceutical compositions that include them. The use of these compounds is aimed at treating diseases or disorders associated with PAD4 enzyme activity. She has 1 patent to her name.
Career Highlights
Audrey is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research in pharmaceutical innovations. Her work has been pivotal in developing new therapeutic options for patients.
Collaborations
Throughout her career, Audrey has collaborated with notable colleagues, including Kumaravel Selvakumar and Venkatram Reddy Paidi. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Audrey Graham Ross exemplifies the spirit of innovation in the pharmaceutical industry. Her work on PAD4 inhibitors showcases her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile